Loss of total CD44 expression has been associated with metastatic spread, and possibly poor prognosis in HNSCC [37], [38], [39], but others have concluded the opposite, that total CD44 expression is associated with metastasis [40], [41], [42]. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.